Form 4: National Healthcare Properties Director Elizabeth Tuppeny Receives Restricted Stock Grant

National Healthcare Properties, Inc. Director Elizabeth K. Tuppeny was granted 3,110 restricted shares of common stock, which will vest in May 2026, bringing her total beneficial ownership to 12,415 shares after a recent reverse stock split.

Summary

• Elizabeth K. Tuppeny, a Director of National Healthcare Properties, Inc., acquired 3,110 restricted shares of the company's common stock on May 23, 2025.
• These shares were granted at a price of $0 and are part of NHP's 2025 Omnibus Incentive Compensation Plan.
• The acquired shares are restricted and will vest on May 22, 2026.
• Following this transaction, Ms. Tuppeny beneficially owns 12,415 shares of Common Stock.
• The total beneficial ownership reflects an adjustment due to a four-for-one reverse stock split effected by NHP on September 30, 2024.
• The Board of Directors approved an estimated per-share net asset value (NAV) of Common Stock of $32.15 as of December 31, 2024, noting there is no established market for the Common Stock.

Sentiment

Score: 7

Explanation: The grant of restricted stock to a director is a positive sign of aligning interests. However, the lack of an established market for the common stock introduces a negative aspect regarding liquidity.

Positives

• The grant of restricted shares to a director aligns management's interests with shareholders, incentivizing long-term performance.
• The company has an Omnibus Incentive Compensation Plan in place, indicating a structured approach to executive and director compensation.

Negatives

• There is no established market for the Common Stock, which could imply illiquidity for shareholders.

Risks

• Lack of an established market for the Common Stock may limit liquidity and price discovery for investors.

Future Outlook

The restricted shares granted to the director are set to vest on May 22, 2026, indicating a future milestone for this compensation.

Management Comments

• The number of shares of Common Stock previously owned by the reporting person has been adjusted to reflect a four-for-one reverse stock split effected by NHP on September 30, 2024.
• On March 26, 2025, the board of directors of NHP approved an estimated per-share net asset value of Common Stock of $32.15 as of December 31, 2024.
• There is no established market for the Common Stock.

Industry Context

This Form 4 filing details an insider transaction, specifically a restricted stock grant to a director, which is a common practice in the healthcare real estate or property sector to align management incentives with long-term company performance. The mention of a reverse stock split and an estimated NAV suggests the company is managing its capital structure and providing internal valuations, which can be relevant in less liquid or privately held real estate investment vehicles.

Comparison to Industry Standards

• NA

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of restricted stock to a director aims to align their interests with shareholders, potentially leading to better long-term performance. The reverse stock split impacts the number of shares held and their per-share value. The lack of an established market for the common stock could affect liquidity for existing shareholders.
• Management/Directors: Elizabeth K. Tuppeny receives equity compensation, incentivizing her performance and commitment to the company.

Next Steps

• Vesting of 3,110 restricted shares on May 22, 2026.

Key Dates

Recommendation

Keywords

National Healthcare Properties, NHP, Elizabeth K. Tuppeny, Form 4, SEC Filing, Restricted Stock, Stock Grant, Director Compensation, Omnibus Incentive Compensation Plan, Reverse Stock Split, Net Asset Value, Corporate Governance, Insider Trading